Replies to post #737126 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

As of June 2024, there is no marketing authorization application submitted to the MHRA for Ojemda (tovorafenib).

https://everyone.org/blog/tovorafenib-approval-in-europe

Take a breather.

[norisknorewards]

when you lose, which is often by the way, you really do like to lose as hard as possible